CLINICAL_TRIALS
research
· 2025-04-09
Clinical Trial Update: FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.
Summary
The Seaver Autism Center at Mount Sinai is conducting a study to characterize FOXP1-related neurodevelopmental disorders using genetic, medical, and neuropsycho…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: FOXP1, Mental Retardation With Language Impairment and With or Without Autistic Features | Status: RECRUITING